Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactodex is a comprehensive range of infant milk formulas and nutritional supplements developed and marketed by Raptakos, Brett & Co. Ltd. The product line is specifically formulated to meet the nutritional requirements of infants at different developmental stages, as well as those with specialized medical needs. Variants include Lactodex 1 and 2 for standard age-based progression, Lactodex LBW for low birth weight infants, and Lactodex HMF (Human Milk Fortifier) for premature neonates. These products typically contain a balanced blend of milk solids, maltodextrin, lactose, vegetable oils, and a fortified profile of essential vitamins and minerals to support healthy physical and cognitive development in infants who are not exclusively breastfed.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lactodex.